Kiwi (Act d 1) IgE

If you have ever had a reaction after eating kiwi, the most important question is not whether you are sensitized to the fruit. It is whether you are sensitized to the specific protein in kiwi that drives the worst reactions. This test addresses that question.

Kiwi (Act d 1) IgE measures antibodies your body has built against actinidin, the major allergy protein in green kiwifruit. People who react to this specific protein tend to have a different and often more severe allergy than people who react only to kiwi proteins that look similar to pollen.

What This Antibody Actually Tells You

Act d 1 (actinidin) is a protein in kiwifruit that makes up about half of the soluble protein in green kiwi. When your immune system mistakes it for a threat, B cells (a type of immune cell) produce immunoglobulin E (IgE), an antibody designed to trigger allergic reactions. Detecting Act d 1 IgE in your blood means your body is primed to react to kiwi itself, not just to a look-alike protein from pollen or latex.

This distinction matters because kiwi allergy is not one disease. Some people react to kiwi only because their birch or grass pollen antibodies happen to also recognize a similar-shaped protein in the fruit. These reactions tend to stay mild, often limited to mouth itching. People with Act d 1 antibodies are usually reacting to kiwi as the original target, and those reactions are more likely to be systemic and severe.

Risk of Severe Reactions and Anaphylaxis

In a European study of 311 people across multiple countries, sensitization to Act d 1 was a strong independent risk factor for severe kiwi allergy. High antibody levels to Act d 1, especially when combined with antibodies to another kiwi protein called Act d 3, are linked to anaphylaxis, the most dangerous form of allergic reaction.

What this means for you: if your test shows Act d 1 antibodies, the safer assumption is that a kiwi reaction could escalate quickly, not stay mild. This shapes how aggressively to avoid kiwi, whether to carry an epinephrine auto-injector, and how to handle accidental exposures.

Primary Kiwi Allergy vs Pollen Cross-Reactivity

Act d 1 antibodies are more common in people who are allergic only to kiwi, with no underlying pollen or latex allergy driving the reaction. In one study, Act d 1 antibodies were found in most kiwi-mono-allergic patients but in none of the atopic controls without kiwi allergy. This is what makes the test useful for sorting out which kind of kiwi problem you actually have.

By contrast, antibodies to other kiwi proteins like Act d 8 (a birch pollen look-alike) and Act d 9 (a profilin) usually point to pollen-related kiwi allergy, where the reaction tends to be localized to the mouth and throat. Knowing which protein your antibodies target changes the conversation about how careful to be.

Why This Beats Standard Kiwi Allergy Testing

Standard commercial kiwi extract blood tests perform poorly. In one study of kiwi-allergic patients, the extract test detected antibodies in only 17% of truly allergic patients. A panel of individual kiwi proteins, including Act d 1, raised detection to 77%. Component-based testing also outperforms extract-based testing and skin prick tests in pooled diagnostic accuracy studies.

The reason extract tests miss so much: kiwi contains an enzyme that breaks down its own proteins, and the fruit varies by ripeness and storage. Testing for the specific Act d 1 protein bypasses that problem and gives a more reliable read on whether your immune system has built true kiwi antibodies.

What a Negative or Low Result Means

A low or undetectable Act d 1 antibody level makes primary kiwi allergy less likely, but it does not fully rule out clinical reactions to kiwi. Some people with genuine kiwi reactions are sensitized to other components in the fruit, and some have negative blood tests despite a clear history. If you have reacted to kiwi but Act d 1 is negative, the next step is usually testing for the other kiwi components or, in some cases, a supervised food challenge.

Why One Reading Is Not the Whole Story

A single number can be misleading. Antibody levels can fluctuate over time, especially in children, where some kiwi allergies eventually resolve and others persist or worsen. Tracking your level over time can be more informative than a single snapshot. If you are working with a specialist on immunotherapy or trying to reintroduce kiwi after years of avoidance, serial measurements help show whether the underlying immune sensitization is shifting.

A reasonable approach is to get a baseline test, retest in 6 to 12 months if your situation is changing (new reactions, new tolerance, immunotherapy), and at least annually if you are actively managing kiwi allergy. If your level is stable and you have not had recent reactions, longer intervals are reasonable. If your level is rising or you have had new exposures, retest sooner.

When Results Can Be Misleading

Antibody levels do not always track perfectly with how severe a reaction will be. Some people have high Act d 1 antibodies and tolerate small amounts of kiwi. Others have moderate levels and react severely. The quality of the antibody (how strongly it binds and triggers immune cells) matters as much as the quantity, and a single blood number cannot capture that.

• Cross-reactive sensitization: if you are allergic to birch pollen, grass pollen, or latex, you may have positive antibodies to other kiwi proteins (Act d 8, Act d 9, Act d 10) that do not necessarily mean clinically dangerous kiwi allergy. Make sure your testing includes Act d 1 specifically, not just a general kiwi panel.
• Total versus specific antibodies: very high overall IgE levels (common in people with eczema, asthma, or multiple allergies) can produce nonspecific positive results across many foods. Interpret Act d 1 in the context of your symptoms, not in isolation.
• Recent immune activation: if you have had a recent severe allergic reaction or are in the middle of treatment for one, antibody dynamics can shift. Testing during a stable period gives a more representative result.
• Assay variability: different laboratories use slightly different methods, so when you retest, try to use the same lab and the same test platform to make comparisons meaningful.

What to Do With an Out-of-Pattern Result

If your Act d 1 antibody comes back positive, especially at a high level, the practical next steps are clear. Strict kiwi avoidance becomes the baseline, including reading labels for kiwi extract in juices, smoothies, and desserts. An allergist visit is worth scheduling, particularly if you have never had a confirmed reaction or have not been evaluated recently. Discuss carrying an epinephrine auto-injector, and have a written action plan in case of accidental exposure.

If the result is unexpected (positive without a history of reactions, or negative despite reactions), the workup should expand. Useful companion tests include a broader component panel covering Act d 2, Act d 5, Act d 8, Act d 9, and Act d 10, and in some cases a supervised oral food challenge. A skin prick test using fresh kiwi can also add information, since it is more sensitive than commercial extracts. The goal is to build a complete picture: which proteins your immune system recognizes, how clinically meaningful that recognition is, and whether your risk is for mild oral symptoms or systemic anaphylaxis.